REPLICATE Trademark

Trademark Overview


On Monday, December 6, 2021, a trademark application was filed for REPLICATE with the United States Patent and Trademark Office. The USPTO has given the REPLICATE trademark a serial number of 97157972. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, March 28, 2024. This trademark is owned by Replicate Bioscience, Inc.. The REPLICATE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and biologic preparations for the treatment of cancer, autoimmune disorders and diseases, inflammatory disorders and diseases, and infectious disorders and diseases; Biological compounds being a component in vaccines; Therapeutic agents and immunotherapies for the treatment of cancer, autoimmune diseases, inflammatory diseases, and infectious diseases; Biological compound for medical use, namely, self-replicating RNAs delivered into patient cells for creating therapeutic proteins; Therapeutic agents for generating or evading protective immune response

Research and development services in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, cancer, autoimmune diseases, inflammatory diseases, and infectious diseases; Providing medical scientific information in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, cancer, autoimmune diseases, inflammatory diseases, and infectious diseases
replicate

General Information


Serial Number97157972
Word MarkREPLICATE
Filing DateMonday, December 6, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, March 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements


Goods and ServicesPharmaceutical and biologic preparations for the treatment of cancer, autoimmune disorders and diseases, inflammatory disorders and diseases, and infectious disorders and diseases; Biological compounds being a component in vaccines; Therapeutic agents and immunotherapies for the treatment of cancer, autoimmune diseases, inflammatory diseases, and infectious diseases; Biological compound for medical use, namely, self-replicating RNAs delivered into patient cells for creating therapeutic proteins; Therapeutic agents for generating or evading protective immune response
Goods and ServicesResearch and development services in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, cancer, autoimmune diseases, inflammatory diseases, and infectious diseases; Providing medical scientific information in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, cancer, autoimmune diseases, inflammatory diseases, and infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 10, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameReplicate Bioscience, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameReplicate Bioscience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Friday, March 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 28, 2024SOU EXTENSION 2 GRANTED
Thursday, March 28, 2024SOU EXTENSION 2 FILED
Thursday, March 28, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 20, 2023SOU EXTENSION 1 GRANTED
Saturday, May 20, 2023SOU EXTENSION 1 FILED
Saturday, May 20, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 26, 2022NON-FINAL ACTION E-MAILED
Monday, September 26, 2022NON-FINAL ACTION WRITTEN
Wednesday, September 14, 2022ASSIGNED TO EXAMINER
Friday, December 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 9, 2021NEW APPLICATION ENTERED